BSE Live
Nov 14, 16:01Prev. Close
417.05
Open Price
415.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:57Prev. Close
417.00
Open Price
414.75
Bid Price (Qty.)
411.15 (7561)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Biocon (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 600.00 | 300.00 | 300.00 | 100.00 | 100.00 | |
| Total Share Capital | 600.00 | 300.00 | 300.00 | 100.00 | 100.00 | |
| Reserves and Surplus | 6,104.90 | 5,797.10 | 4,879.90 | 4,736.80 | 3,932.90 | |
| Total Reserves and Surplus | 6,105.80 | 5,798.00 | 4,880.80 | 4,737.70 | 3,933.80 | |
| Total Shareholders Funds | 6,705.80 | 6,098.00 | 5,180.80 | 4,837.70 | 4,033.80 | |
| Minority Interest | 677.30 | 608.90 | 467.70 | 376.10 | 265.80 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,222.20 | 1,525.60 | 1,789.80 | 2,108.20 | 2,072.40 | |
| Deferred Tax Liabilities [Net] | 29.80 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 1,714.90 | 855.30 | 360.80 | 357.90 | 390.50 | |
| Long Term Provisions | 85.80 | 66.10 | 49.30 | 36.00 | 29.90 | |
| Total Non-Current Liabilities | 3,052.70 | 2,447.00 | 2,199.90 | 2,502.10 | 2,492.80 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 667.60 | 261.20 | 130.30 | 97.20 | 394.90 | |
| Trade Payables | 1,325.10 | 1,198.30 | 1,005.30 | 739.70 | 609.80 | |
| Other Current Liabilities | 1,912.30 | 1,498.50 | 959.20 | 794.60 | 623.60 | |
| Short Term Provisions | 103.00 | 80.50 | 46.50 | 46.80 | 37.40 | |
| Total Current Liabilities | 4,008.00 | 3,038.50 | 2,141.30 | 1,678.30 | 1,665.70 | |
| Total Capital And Liabilities | 14,443.80 | 12,192.40 | 9,989.70 | 9,394.20 | 8,458.10 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 5,521.50 | 4,252.70 | 3,629.70 | 3,553.70 | 1,681.10 | |
| Intangible Assets | 423.20 | 191.90 | 43.40 | 45.80 | 40.80 | |
| Capital Work-In-Progress | 1,576.50 | 1,286.90 | 778.90 | 532.70 | 2,059.70 | |
| Fixed Assets | 8,140.70 | 6,343.50 | 4,975.90 | 4,438.70 | 3,962.30 | |
| Non-Current Investments | 108.50 | 182.50 | 63.80 | 188.00 | 25.90 | |
| Deferred Tax Assets [Net] | 368.00 | 324.70 | 193.40 | 197.50 | 71.50 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 475.20 | 426.80 | 581.60 | 495.90 | 401.10 | |
| Total Non-Current Assets | 9,118.80 | 7,303.90 | 5,841.10 | 5,346.50 | 4,487.20 | |
| CURRENT ASSETS | ||||||
| Current Investments | 857.60 | 829.30 | 611.40 | 1,065.00 | 874.70 | |
| Inventories | 1,435.90 | 1,031.60 | 722.50 | 635.30 | 542.40 | |
| Trade Receivables | 1,223.70 | 1,291.80 | 1,063.90 | 883.20 | 714.50 | |
| Cash And Cash Equivalents | 998.60 | 1,057.20 | 1,322.80 | 1,044.30 | 1,538.60 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 809.20 | 678.60 | 428.00 | 419.90 | 300.70 | |
| Total Current Assets | 5,325.00 | 4,888.50 | 4,148.60 | 4,047.70 | 3,970.90 | |
| Total Assets | 14,443.80 | 12,192.40 | 9,989.70 | 9,394.20 | 8,458.10 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1,489.90 | 1,600.60 | 1,115.90 | 786.50 | 803.60 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 593.47 | 293.47 | 293.47 | 93.47 | 93.47 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 38.20 | 0.20 | 0.00 | 167.80 | 34.90 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 56.30 | 119.30 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 801.30 | 710.00 | 145.80 | 212.00 | 874.70 |
14.11.2025
12.11.2025
Biocon Standalone September 2025 Net Sales at Rs 583.30 crore, up 11.02% Y-o-Y
10.11.2025
07.11.2025